Mycobacterium tuberculosis is a facultative intracellular pathogen that resides and multiplies within human macrophages. Gamma interferon (IFN-␥), the predominant inducer of macrophage-mediated microbicidal functions (36), has been shown to be required for the prevention of progressive M. tuberculosis infection (13, 19) . In tuberculosis patients, IFN-␥ has been detected in CD4
Mycobacterium tuberculosis is a facultative intracellular pathogen that resides and multiplies within human macrophages. Gamma interferon (IFN-␥), the predominant inducer of macrophage-mediated microbicidal functions (36) , has been shown to be required for the prevention of progressive M. tuberculosis infection (13, 19) . In tuberculosis patients, IFN-␥ has been detected in CD4
ϩ T cells and culture supernatants (8) as well as in infectious foci (7) . Despite the availability of IFN-␥, the immune system is unable to eradicate the infection, indicating that M. tuberculosis selectively inhibits macrophage responsiveness to IFN-␥ (56, 61) . This reduced response results in the inefficient induction of IFN-␥-inducible genes, such as major histocompatibility complex class II and others (24, 61) .
IFN-␥ binds to its cell surface receptor, IFN-␥R, which consists of two heterodimeric subunits, IFN-␥R1 (␣, ligand binding) and IFN-␥R2 (␤, signaling subunit) (6) . The IFN-␥R is expressed on lymphoid cells (such as monocytes/macrophages, T, B, and NK cells) and nonlymphoid cells (such as fibroblasts and endothelial cells) (62) . Various infections, such as Leishmania donovani (43) , Trypanosoma cruzi (23) , and Mycobacterium avium (22) , have been shown to down modulate IFN-␥R1 expression. In addition, individuals with mutations in IFN-␥R genes have been shown to be susceptible to mycobacterial infections (reviewed in reference 17) . This provides convincing evidence that the functional integrity of this receptor is crucial in the defense against mycobacterial infection in humans.
The aim of this study was to investigate the cellular mechanism by which M. tuberculosis modulates the expression of IFN-␥R1. Our results indicate that M. tuberculosis down regulates the expression of IFN-␥R1 in human cells, such as peripheral blood mononuclear cells (PBMCs), CD14 ϩ cells, and phorbol myristate acetate (PMA)-differentiated THP-1 cells (pdTHP-1). Further, M. tuberculosis down regulates the transcription of IFNGR1 by inhibiting the expression of stimulating protein 1 (Sp1) in pdTHP-1 cells. The binding and interaction of IFN-␥ with its heterodimeric receptor mediate the signaling cascade, which in due course leads to the expression of IFN-␥-responsive genes (1) . The inability of infected cells to respond to IFN-␥, owing to the down modulation of IFN-␥R1 expression, leads to the survival and persistence of M. tuberculosis in the infected host.
itant intracellular infections in the individuals enrolled. The study was approved by the institutional ethical committee.
Reagents. The following reagents were procured-anti-human IFN-␥R1-phycoerythrin, anti-human leukocyte antigen DR alpha (HLA-DR␣)-fluorescein isothiocyanate (FITC), and anti-CD14-FITC monoclonal antibodies (Abs); recombinant human IFN-␥ (Pharmingen); anti-Sp1 Ab (eBioscience); reverse transcription-PCR (RT-PCR) reagents, DNase and Taq DNA polymerase (MBI Fermentas); protease inhibitor (Roche Diagnostics); anti-mouse-horseradish peroxidase Ab (Bangalore Genei); Trizol, RPMI 1640, and fetal calf serum (FCS) (Invitrogen); pGL3 basic luciferase vector (Promega); DEAE-dextran and Ficoll-Hypaque (Sigma); and PMA, luciferase estimation kit, and SYBR Premix Ex Taq (Clontech).
Mycobacterium cultivation. M. tuberculosis H37Rv was grown in 7H9 supplemented with 10% albumin-dextrose complex and 0.1% Tween 80, with shaking at 200 rpm at 37°C until an optical density at 590 nm of 0.6 to 0.8 was reached. The culture was vortexed along with 3-mm glass beads and allowed to stand for 20 min. The single-cell suspension was retrieved from the top and used in infection experiments. Similarly, Mycobacterium smegmatis mc 2 was propagated in LuriaBertani (LB) supplemented with 10% glycerol, and a single-cell suspension was prepared.
Isolation of human PBMCs and infection with mycobacteria. PBMCs were isolated from patients and healthy donors by Ficoll-Hypaque gradient centrifugation as described previously (8) . Isolated PBMCs were washed with RPMI, resuspended in RPMI supplemented with 10% autologous serum, and maintained for 30 min at 37°C in 5% CO 2 before infection. PBMCs from healthy donors were cocultured with M. tuberculosis/M. smegmatis mc 2 (multiplicity of infection [MOI] ϭ 1:1) for various time points as indicated. After infection, PBMCs were harvested and stained for IFN-␥R1 and CD14/processed for RT-PCR analysis. Uninfected PBMCs were included as controls.
THP-1 cell culture, M. tuberculosis infection, and IFN-␥ stimulation. THP-1 cells (NCCS, Pune, India) were maintained in RPMI supplemented with 10% FCS and 100 U/ml penicillin G and differentiated by PMA (20 ng/1 ϫ 10 6 cells/ml) for 24 h (30). pdTHP-1 cells were cocultured with live M. tuberculosis (MOI ϭ 1:1)/whole-cell lysate of M. tuberculosis (WCL; TB research material, NIH). Cells were washed and incubated with IFN-␥ (100 U/ml). After 24 h, cells were harvested and processed for flow cytometric/RT-PCR analysis/nuclear extract preparation along with controls.
Staining of PBMCs and THP-1 cells and flow cytometric analysis. PBMCs (infected and uninfected and/or for basal-level expression) suspended in staining buffer (phosphate-buffered saline with 1% FCS) were incubated for 45 min on wet ice with anti-IFN-␥R1 and anti-CD14 Abs to stain surface IFN-␥R1 and CD14. THP-1 cells were similarly stained for surface CD14, HLA-DR␣, and IFN-␥R1 expression. For the staining of total IFN-␥R1 expression in THP-1 cells, cells were first permeabilized and then incubated with anti-IFN-␥R1 Ab. Stained cells were washed and fixed overnight in 1% paraformaldehyde. A total of 20,000 cells were acquired per sample for flow cytometric analysis (Becton Dickinson; courtesy of the NII, New Delhi, India). The data were analyzed using CellQuest software.
Real-time RT-PCR for IFN-␥R1 expression. Real-time RT-PCR for IFN-␥R1 expression was performed on cDNA samples as described previously (35) . For the amplification of IFN-␥R1 and housekeeping (␤-actin) genes, the following primers were used: IFN-␥R1-forward (5Ј CATCACGTCATACCAGCCATTT 3Ј), IFN-␥R1-reverse (5Ј CTGGATTGTCTTCGGTATGCAT 3Ј), ␤-actin-forward (5Ј TTGTTACAGGAAGTCCCTTGCC 3Ј), and ␤-actin-reverse (5Ј ATG CTATCACCTCCCCTGTGTG 3Ј). Briefly 2 g of DNase-treated RNA was used to prepare cDNA. Duplicate reactions were set up using SYBR Premix Ex Taq, and 0.5 M of each pair of primers and samples (2.5 l of cDNA) was subjected to thermal cycling on a Bio-Rad MyIQ under the following conditions: 95°C for 30 s for stage 1 and 95°C for 15 s, 58°C for 20 s, and 72°C for 40 s for stage 2. Stage 2 was repeated for 35 cycles. Relative quantification of IFN-␥R1 for each sample used was performed using the standard curve method and was normalized to the level of the endogenous control, ␤-actin. This was done to account for variability in the (i) initial concentration and quality of total RNA and (ii) conversion efficiency of the reverse transcription reaction. For the quantitation of IFN-␥R1 transcripts normalized to ␤-actin, standard curves were prepared for both IFN-␥R1 and ␤-actin. For each experimental sample, the amounts of both IFN-␥R1 and ␤-actin were determined from the standard curve. The normalized values have been presented as ratios of IFN-␥R1 to ␤-actin.
Semiquantitative RT-PCR of HLA-DR␣ expression. RNA isolated from THP-1 cells and PBMCs was treated with DNase, and 2 g was used to prepare cDNA. To the 25-l reaction mixture (0.2 mM each of dATP, dTTP, dCTP, and dGTP; 0.4 M of each pair of primers), 1 U of Taq DNA polymerase and 2.5 l of 10ϫ buffer and cDNA were added. The reaction mixture was subjected to an initial denaturation at 94°C for 5 min and 35 cycles each of denaturation at 94°C for 30 s, annealing at 55°C for 30 s, and extension at 72°C for 45 s. The annealing temperature for GAPDH was 60°C, and amplification was for 30 cycles. GAPDH gene expression was used to normalize the cDNA used. PCR products were separated by agarose gel (2%) electrophoresis and visualized by ethidium bromide staining. The primer sequences and the expected sizes of the amplified products were as follows: 5Ј CGAGTTCTATCTGAATCCTGACCA 3Ј (forward), 5Ј GTTCTGCTGCATTGCTTTTGCGCA 3Ј (reverse), and 693 bp for HLA-DR␣ and 5Ј TGAAGGTCGGAGTCAACGGAT 3Ј (forward), 5Ј CGGT GCCATGGAATTTGCCA 3Ј(reverse), and 167 bp for glyceraldehyde-3-phosphate dehydrogenase.
Plasmid construction. Luciferase reporters containing the 5Ј deletion constructs of the human IFNGR1 promoter (GenBank accession number U19241) in a pGL3 basic luciferase vector were constructed as described previously (49) . pGLR1A, pGLR1B, and pGLR1C have IFNGR1 promoters from Ϫ840 to ϩ1 bp, Ϫ128 to ϩ1 bp, and Ϫ109 to ϩ1 bp, respectively.
Transient transfection of THP-1 cells. The DEAE-dextran method was used to transfect THP-1 cells with modifications (65) . A total of 1 ϫ 10 7 cells were washed with TBS (25 mM Tris-HCl, pH 7.4, 137 mM NaCl, 5 mM KCl, 0.6 mM Na 2 HPO 4 , 7 mM CaCl 2 , and 5 mM MgCl 2 ) and resuspended in 1 ml of TBS containing 5 g of reporter plasmid DNA and 500 g DEAE-dextran. The cells were incubated for 30 min at room temperature, washed with RPMI, resuspended in 12 ml of RPMI with 10% FCS, and plated. The cells were allowed to stabilize for 6 h. Following this, cells were cocultured with live M. tuberculosis (MOI ϭ 1:1) or WCL (500 g) for an additional time period of 36 h. PMA (20 ng/ml) was added 21 h posttransfection. All cultures were terminated at 42 h. Lysates were prepared and filtered (0.45 m) to remove M. tuberculosis. The luciferase activity was estimated, and the results are expressed as the relative intensity of light generated by luciferase (RLU) per microgram of protein of the lysate. The protein concentration was estimated by the Bradford method (9).
Nuclear extract preparation and electrophoretic mobility shift assay (EMSA). Nuclear protein extracts were prepared from infected and uninfected cells (27) . Extracts prepared were filtered (0.45 m) to remove M. tuberculosis. A synthetic double-stranded oligonucleotide containing the sequence of the phorbol esterresponsive element (PRE) of the IFNGR1 promoter (5Ј-GGTCCCGCCTCCT GCCGA-3Ј) was end labeled with [␥-32 P]ATP by using T4 polynucleotide kinase (49) . Each 20-l reaction mixture contained 20,000 cpm of labeled PRE, 1.5 to 2.0 g of nuclear extracts, and 0.25 g of poly(dI-dC) in binding buffer (10 mM Tris-HCl, pH 7.5, 5 mM NaCl, 10 mM MgCl 2 , 5 mM CaCl 2 , 5% glycerol, and 1 mM EDTA). The mixture was incubated at 4°C for 30 min and electrophoresed on a 6% polyacrylamide gel (0.5ϫ Tris-borate-EDTA; 100 V for 1 h). The DNA-protein complex was visualized by autoradiography. For competitive assays, a 100-fold excess of unlabeled double-stranded PRE and anti-Sp1 Ab was used. Densitometric analysis was performed using Labworks software (UVP, United Kingdom).
Immunoblot analysis of Sp1. Nuclear proteins (15 g) separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis were electroblotted onto nitrocellulose membranes. The electroblots were blocked, probed with murine polyclonal anti-human Sp1 Ab, washed (phosphate-buffered salineTween 20), and incubated with horseradish peroxidase-conjugated rabbit antimouse immunoglobulin G. The bound Ab was visualized by ECL (Amersham, IL). Densitometric analysis was performed as described above.
Statistical analysis. Nonparametric Mann-Whitney test, two-tailed, unpaired Student's t test, and one-way analysis of variance (ANOVA) with Tukey's test were used to analyze the data.
RESULTS

Decreased surface expression of IFN-␥R1 in PBMCs and CD14
؉ cells of PTB patients compared to that in healthy controls. Flow cytometric estimation of the basal surface level expression of IFN-␥R1 on PBMCs isolated from PTB patients and healthy individuals was performed. Acquired cells were gated for mononuclear cells, and the mean fluorescence intensity (MFI) of IFN-␥R1 ϩ cells was calculated. The representative MFI profiles (histogram) seen in a patient and a healthy control are depicted in Fig. 1A . It was observed that the MFI for surface expression of IFN-␥R1 was lower in patient-derived PBMCs (3.9) than in PBMCs from the healthy control (9.10) (Fig. 1A) . The cumulative MFI for the surface expression of IFN-␥R1 on PBMCs from patients (n ϭ 13) was 4.6 Ϯ 1.1, compared to that of PBMCs from controls (n ϭ 9; 8.9 Ϯ 0.6) (P Ͻ 0.01). IFN-␥R1 surface expression on CD14 ϩ cells was also estimated. It was observed that the mean percentage Ϯ standard deviation (SD) of CD14 ϩ cells expressing IFN-␥R1 in patient-derived PBMCs (n ϭ 9; 31.4 Ϯ 11.9) was significantly lower than that of PBMCs from healthy controls (n ϭ 9; 88.7 Ϯ 8.1; P Ͻ 0.001) (Fig. 1B) .
Recovery of IFN-␥R1 surface expression on PBMCs of PTB patients upon ATT. For this part of the study, a cohort of six PTB patients was assessed for the surface expression of IFN-␥R1 on PBMCs prior to the initiation of ATT and at 2 and 4 months, respectively. Prior to ATT, the MFI of surface expression of IFN-␥R1 on PBMCs was 4.8 Ϯ 0.5 ( (Fig. 4) . Time-dependent down modulation of IFNGR1 transcripts was observed for M. tuberculosis-infected PBMCs compared to uninfected controls, indicating that the down modulation in IFN-␥R1 surface expression by M. tuberculosis (Fig. 3) was due to the decreased expression of IFNGR1. M. tuberculosis infection significantly (P Ͻ 0.01) down regulates the IFN-␥R1 mRNA expression at 4 h after infection. This trend continued for up to 18 h postinfection. The reduction in IFN-␥R1 mRNA expression was three-to fivefold compared to that for uninfected controls (P Ͻ 0.01).
M. smegmatis does not modulate IFN-␥R1 surface expression on CD14
؉ cells. In order to assess the specificity of the modulation of IFN-␥R1 by M. tuberculosis, a pathogenic mycobacterium, viz., M. smegmatis mc 2 (a nonpathogenic mycobacterium), was Fig. 6A and B) . M. tuberculosis infection inhibited both IFN-␥R1 surface and total (surface and intracellular) expression by ϳ50% compared with uninfected cells (P Ͻ 0.01) (Fig. 6B) . To correlate the decrease in surface expression with the decrease in IFNGR1 transcripts in M. tuberculosis-infected pdTHP-1 cells, as observed with PBMCs ( Fig. 3 and 4) , quantitative real-time RT-PCR was performed on RNA isolated from uninfected and infected pdTHP-1 cells. An increase in IFN-␥R1 mRNA transcripts was observed in pdTHP-1 cells compared to that in THP-1 cells (P Ͻ 0.01) (Fig. 6C) . Significant reduction in IFNGR1 mRNA was observed in M. tuberculosis-infected pdTHP-1 cells compared to that in uninfected pdTHP-1 cells (P Ͻ 0.01) (Fig. 6C) . M. tuberculosis infection resulted in a seven-to eightfold decrease in IFNGR1 mRNA in pdTHP-1 cells. (Fig. 7A ) and RT-PCR (Fig. 7B, lanes 3 and 4) analysis showed that IFN-␥-mediated HLA-DR␣ expression was detected in uninfected and M. tuberculosis-infected pdTHP-1 cells. However, HLA-DR␣ expression was significantly reduced (ϳ66%, P Ͻ 0.01) in infected cells compared to that in uninfected cells (Fig.  7A and B) .
M. tuberculosis infection of pdTHP-1 cells inhibits IFN-␥-mediated HLA-DR␣ expression. Flow cytometric
M. tuberculosis infection of pdTHP-1 cells inhibits IFNGR1 promoter activity. PRE (Fig. 8A) is located in the Ϫ128-to Ϫ109-bp region of the IFNGR1 promoter (49) . 5Ј deletion constructs of the IFNGR1 promoter were constructed in a pGL3 basic luciferase vector (Fig. 8B) . To determine the effect of M. tuberculosis on the promoter activity of IFNGR1, the constructs were transfected into THP-1 cells and cocultured with live M. tuberculosis (MOI ϭ 1:1; ϳ250 ng of protein)/ WCL (500 g protein) and the levels of luciferase activity were determined (14) . Figure 8B shows the structure of the deletion derivatives used in the study. The corresponding promoter activities are shown in Fig. 8C . A twofold inhibition of pGLR1B promoter activity by live M. tuberculosis was observed (Fig. 8C ) (P Ͻ 0.05). Similar inhibition of pGLR1A and pGLR1B promoter activity was observed with WCL (P Ͻ 0.05), suggesting that M. tuberculosis mediated the inhibition of IFNGR1 promoter activity.
M. tuberculosis inhibits expression of Sp1 and its recruitment on the PRE of the IFNGR1 promoter. Binding of Sp1 to the PRE of the IFNGR1 promoter has been shown to induce the up regulation of IFNGR1 expression (49) . Initially Sp1 expression in the nuclear extracts prepared from M. tuberculosis-infected pdTHP-1 cells was investigated (Fig. 9A, panel i) . A densitometric plot of the Sp1 expression detected in various experimental conditions has been depicted in Fig. 9A, panel ii. PMA differen- Figure 9B shows the competitive EMSA for Sp1 interaction. The presence of a 100-fold excess of unlabeled PRE (Fig. 9B, lane 3 ) and 2.5 g of anti-Sp1 Ab (lane 4) resulted in the disappearance of the major DNA-Sp1 complex seen (lane 2). Further, the interaction of equivalent amounts of nuclear extracts (1.5 g) derived from undifferentiated, differentiated, and infected THP-1 cells with PRE was carried out (Fig.  9C, panel i) . Figure 9C , panel ii, depicts the relative intensity of the DNA-Sp1 complex detected. The intensity of DNA-Sp1 complex (Fig. 9C , panel i, lane 3) with a nuclear extract of pdTHP-1 cells was found to be more intense compared to that of a nuclear extract of undifferentiated cells (Fig. 9C, panel i, lane 2) . Reduced intensity of DNA-Sp1 complex was observed when a nuclear extract of M. tuberculosis-infected pdTHP-1 cells was used (Fig.  9C, panel i, lane 4) .
DISCUSSION
The ability of M. tuberculosis to persist within macrophages is known to be facilitated by various mycobacterium-induced evasion strategies. These include inhibition of the recognition of infected macrophages by T cells and macrophage-killing mechanisms (18) . IFN-␥ signals are mediated through its heterodimeric receptor (6), of which the IFN-␥R1 chain binds the ligand and determines signaling specificity (37) . As infected human macrophages cannot be activated by IFN-␥ to kill intracellular tubercle bacilli (61) observed similar results of no effect of M. tuberculosis on STAT1 tyrosine phosphorylation (data not shown). Despite the down modulation of the IFN-␥R1 receptor, the details of the pathways associated with sustained STAT1 activation levels in M. tuberculosis-infected cells remain elusive.
This elusiveness could be due to the existence of multiple mechanisms for enhancing cytokine-induced STAT1 activation and function (60) . STAT1 has been shown to participate in cross talk between signal-transduction pathways (40) . Apart from IFN-␥-induced STAT1 activation, the dimerization of tyrosine-phosphorylated STAT1 monomers has been shown to be mediated by the interaction of type I interferon and IL-6 receptors in caveolar domains in the plasma membrane (33, 59) . Tassiulas responsive genes without inhibiting the activation or function of STAT1 (34) . The existence of various STAT1 activation factors in addition to interferons has also been suggested (60) . Prolactin (a hormone) has been shown to induce homodimerization and tyrosine phosphorylation of STAT1 (51) . STAT1 activation has also been reported to occur during spontaneous in vitro differentiation of monocytes into macrophages, wherein it is induced by the adherence of monocytes to plastic surfaces (12) . Further, fibronectin and laminin, host adhesion molecules present in the extracellular matrix (ECM), have been shown to enhance STAT1 activation by an unknown mechanism(s) (12) . Various mycobacterial proteins, such as Ag85B (2) (55) . Despite optimal STAT1 activation in M. tuberculosis infection, the IFN-␥-mediated signal transduction pathway remains impaired, indicating the existence of an alternate pathway for the inhibition of IFN-␥-mediated signaling. PIASy, a member of the PIAS (protein inhibitor of activated STAT1) family, has been shown to function as a repressor of STAT1-dependent signaling (28) . It binds to STAT1 and represses STAT1-mediated gene activation without blocking the ability of STAT1 to bind to DNA (28) . The role of PIASy in M. tuberculosis infection is yet to be elucidated. Further, there exist numerous STAT1-independent pathways that play crucial roles in IFN-␥-mediated signaling (41) . Whether the evasion of IFN-␥-dependent microbicidal effects by M. tuberculosis is due to the subversion of these STAT1-independent pathways remains unanswered.
It is possible that M. tuberculosis infection of THP-1 cells/ PBMCs may interfere with the recycling of IFN-␥R1 or enhance its degradation by altering mRNA stability. Curry et al. (15) showed that M. avium-mediated down regulation of IFN-␥R1 expression in mouse macrophages was not due to reduced mRNA stability but to decreased levels of mRNA. This decrease in mRNA levels was shown to be related to alterations in the transcription rate. A similar scenario may exist in cells harboring M. tuberculosis. We found reduced mRNA levels of IFN-␥R1 in M. tuberculosis-infected pdTHP-1 cells. Further, the stimulation of transiently transfected THP-1 cells by live M. tuberculosis and WCL resulted in the decreased transcription of human IFNGR1. The degree of inhibition of IFNGR1 promoter activity by live M. tuberculosis (ϳ250 ng of protein) (14) was found to be equivalent to that observed by 500 g protein of WCL. Thus, integral bacilli showed a more potent effect on transcriptional inhibition of IFNGR1 than did WCL.
The IFNGR1 promoter is GC rich with no TATA box and is similar to the promoters of noninducible housekeeping genes (38) . The Sp1 family of transcription factors have been shown to regulate the initiation of transcription in promoters devoid of the TATA box (3, 57) . It was shown earlier that the expression of Sp1 increases in pdTHP-1 cells (27) and is related to the up regulation of IFN-␥R1 by binding to the PRE of the IFNGR1 promoter (49) . In the present study, we observed that M. tuberculosis down regulates not only the expression of Sp1 in pdTHP-1 cells but also its recruitment on the PRE of the IFNGR1 promoter. Reduced DNA binding activity of Sp1 could be a result of posttranslational modification, as phosphorylation has been shown earlier to have a profound effect on DNA binding activity of Sp1 (39) . This has not been investigated in the present study. Hence, it could be speculated that the down regulation of Sp1 resulted in the decrease of IFN-␥R1 expression in M. tuberculosis-infected pdTHP-1 cells. Little is known about the transcriptional regulation of human IFNGR1. Regulatory motifs present in mouse IFNGR1 include multiple Sp1, Ap2, NF1, and CRE sites (42) . Additionally, Sp1 is known to interact with several transcription factors, such as Oct-1 (58), nuclear factor Y (45), SREBP-2, ELF-1, etc. Thus, besides Sp1 modulation, the modulation of other factors which bind to the IFNGR1 promoter and possibly to Sp1 could be important in the M. tuberculosis-induced down regulation of IFN-␥R1 expression.
Sp1 is a ubiquitous transcriptional factor which also has been show to be involved in the regulation and expression of the human monocytic-specific gene CD14 (64) . We observed that the expression of CD14 in pdTHP-1 cells remained unchanged following M. tuberculosis infection (MOI ϭ 1:1) (data not shown), indicating that decreased Sp1 expression by M. tuberculosis had no effect on the expression of CD14. This may be because the level of Sp1 in infected pdTHP-1 cells was ϳ3-fold higher than that in undifferentiated THP-1 cells (Fig. 9A) , which could be adequate to maintain the expression of CD14. Besides Sp1, other transcriptional factors, such as AP-1, have been shown to play critical roles in the expression of CD14 in the murine and rat systems (29, 31) In conclusion, we detected reduced IFN-␥R1 expression levels in untreated PTB patients. The IFN-␥R1 expression was restored in these individuals following ATT. The down modulation of IFN-␥R1 expression was observed in ex vivo experiments, wherein PBMCs were cocultured with M. tuberculosis. The down regulation of IFN-␥R1 expression by M. tuberculosis was confirmed by using PMA-differentiated THP-1 cells and was found to be related to the reduced transcription of the IFNGR1 gene. This may be due to the decreased Sp1 expression and its recruitment on the PRE of the IFNGR1 promoter. Therefore, the down regulation of IFN-␥R1 could be one of the probable mechanisms employed by M. tuberculosis to alter the responsiveness of an infected cell to IFN-␥, thereby inhibiting potential IFN-␥-mediated microbicidal functions of macrophages.
